Progress in treatment of small-cell lung cancer: role of CPT-11.

Br J Cancer · 2003 · PMC2395289 · PMID 14676791

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Treatment with four cycles of CPT-11+ CDDP every 4 weeks yielded a highly significant improvement in survival in ED-SCLC over standard VP-16+ CDDP, with less myelosuppression.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.